NTRA Natera Inc

$NTRA $CYDY Think about it! 10share of NTRA can get you 15,765 shares of CYDY as of Friday’s close..

Some large OTM orders for $NTRA calls - $1.9M+ bought of the Jan. 15th $400 call - $1.3M+ bought of the Jan. 15th $460 call

$NTRA everything selloff. Great time to start looking at this one. Not AI related tech and hot

The diagnostics space has been hot hot hot. We bankeda nice win in $NTRA in the Live Trading Room. Had $ILMN unofficially (ER tonight). $IQV also good among others:

$NTRA holders: an open class action alleges Natera billed patients for genetic tests without clear out-of-pocket cost disclosures. $9.5M settlement, up to $50 per claim, deadline May 3, 2027. Open Class Actions.

$NTRA update: Natera’s $8.25M settlement over allegedly misleading billing for its Panorama prenatal tests awaits its final-approval ruling after the Aug 20 hearing. Claims closed; payout automatic for valid claims. Open Class Actions.

$NTRA Natera's clinical diagnostics president sold 3,000 shares Thursday, about $1.24 million at an average $414.22 a share (SEC Form 4). It was a pre-arranged 10b5-1 sale, so not a timing call. But the pattern stands out: he has sold into the strength all summer, including 15,160 shares in early September at $326.89, and still holds 106,914 shares worth about $44 million. The valuation arithmetic: Natera closed Friday at $410.35, about 20 percent above the Street's $341.55 average target, after a 25 percent four-week run on quarterly revenue up 37.7 percent YoY to $752.75 million. The tape has moved ahead of the Street's own numbers.

$NTRA printing money like the Fed feels niceee. Don’t forget to sign up for my alerts. Oh wait lol

$NTRA: check the first letter of your Class Member ID in Calcaterra. A means Natera records show you paid over the threshold and share 94.7% of the net fund. B caps at $50. Claim by May 3, 2027. Open Class Actions.

$NTRA goes on greens list. This is a good example of what can work until we get past midterms: strong uptrend, consolidation at/near highs, above all MA's, indicators not OB, and ER not immediate.

$NTRA Druckenmiller's biggest bet isn't tech 🧬 Natera is his #1 holding at 16.6% of the portfolio, per his latest 13F proprietary data from our GTA terminal

$NTRA The problem with short-selling fraudsters is the information they bring. This combination—of truth and concealment—is what's terrible, and fraudsters specialize in it. So they bring you information, but just forget to add that the lawsuit regarding the $9.5 million billing settlement had already been known to the market for a long time. Furthermore, this specific settlement amount represents less than 0.02% of Natera’s massive $60 billion market capitalization.

$NTRA $NTRA Reny is going to drop some knowledge!! 1PM Pacific Time 4 PM Eastern. #leronlimab is a a major cancer breakthrough!!!!!!!!!! "Pashtoon M. Kasi, M.D., M.S., Medical Director of GI Oncology, City of Hope Orange County, Irvine, California. Reny Aniline, Senior Director of BioPharma Business Development of Natera, Inc., will also participate in the webcast to discuss the recently announced strategic collaboration between Natera and CytoDyn, and to provide further context on the early ctDNA observations in CytoDyn’s CLOVER study."

$NTRA Morgan Stanley lifted its target to 435 from 355 on Monday, Overweight kept. That landed three days after the FDA granted Breakthrough Device designation to Natera's multi-cancer early detection assay, based on data across 12 cancer types. It is not an approval. The assay is still investigational, and Natera has not disclosed the sensitivity or specificity numbers behind the designation. Shares closed Monday at 397.77, up about 20% in the last month.

Natera is near its 52-week high, with sales up 38% on the year. The company is an Excellent 16 on the Quality Score, #90 of 3,283. $NTRA

$NTRA elephantitis Kid, what's up? Breathe. Wipe your mouth. Good boy. After the gains we had (especially yesterday), there is now some profit-taking. It's fine, that's how a healthy stock behaves. So keep watching, keep investing your 10 dollars in some obscure stock, and stop writing foolish posts for us. Thanks in advance.

$NTRA Perfect 👀 Price has rejected off the 1 fib extension perfectly, and I'm certainly in no rush to buy this. I expect a move into the buyzone over the coming 12-24 months. Patience.